OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announced today that further to the announcements dated 5 January 2017 and 18 January 2017 and completion of the normal regulatory due diligence, Per Rehné and Christina Wood have been appointed to the Board of OptiBiotix. This follows on from their appointments to the Company in January.
As previously announced on 5 January 2017, Per has many years’ experience of the food industry, having worked for some of the world’s leading food companies including most recently Cornelius Group plc where he acted as European Director of Health and Nutrition.
As announced by OptiBiotix Health plc on 18 January 2017, Christina has 25 years’ sales experience within the food, nutrition, and nutraceuticals industry. As the owner and CEO of Confoco, a supplier of high quality food ingredients worldwide, Christina grew the business from £1m to £11m sales by obtaining strategic supplier status with multiple global corporates including Nestlé, Danone, and Heinz.
Christina Mary Wood
Pursuant to Rule 17 and Schedule Two (g) of the AIM Rules, the following information is disclosed in respect of Christina Mary Wood (aged 57):
Current Appointments
None
Appointments in the last 5 years
John Morley (Importers) Limited
Confoco International Limited
Per Rehné
Pursuant to Rule 17 and Schedule Two (g) of the AIM Rules, the following information is disclosed in respect of Per Rehné (aged 47):
Current Appointments
None
Appointments in the last 5 years
Cornelius Group Plc
Cornelius Nordic APS
Custom Fiber Europe N.V.
Rehné Consult 2014 ApS
DJAP Holdings ApS
K/S Welford Place
Welford Place Komplementar ApS
